The total return over the past 12 months is -82.13% vs. +16.94% for the S&P 500. So far it's up -55.21% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (82.13%) | (65.16%) | (49.16%) | N/A | N/A | N/A |
| Total Return CAGR | (82.13%) | (65.16%) | (49.16%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Quantum BioPharma Ltd. (QNTM)
| Year | Start price | End price | QNTM Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $7.30 | $3.27 | (55.21%) | +14.51% | (69.72%) |
| 2025 | $3.68 | $7.30 | +98.37% | +17.72% | +80.65% |
| 2024 | $59.80 | $3.68 | (93.85%) | +24.89% | (118.74%) |
| 2023 | $51.22 | $59.80 | +16.75% | +26.19% | (9.44%) |
| 2022 | $66.30 | $51.22 | (22.75%) | (18.17%) | (4.58%) |
| 2021 | $101.40 | $66.30 | (34.62%) | +28.74% | (63.36%) |
| 2020 | $352.89 | $101.40 | (71.27%) | +18.37% | (89.64%) |
| 2019 | $2,795.91 | $352.89 | (87.38%) | +31.22% | (118.60%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
